According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034.
Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek